Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
May 16, 2023	4	Statement of changes in beneficial ownership of securities	0001562180-23-004169.pdf 0001562180-23-004169.rtf 0001562180-23-004169.xls View HTML
May 16, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	0001517022-23-000002.pdf 0001517022-23-000002.rtf 0001517022-23-000002.xls View HTML
May 16, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	0001517022-23-000003.pdf 0001517022-23-000003.rtf 0001517022-23-000003.xls View HTML
May 9, 2023	8-K	Report of unscheduled material events or corporate event	0001193125-23-139506.pdf 0001193125-23-139506.rtf 0001193125-23-139506.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 8, 2023	8-K	Report of unscheduled material events or corporate event	0001193125-23-137689.pdf 0001193125-23-137689.rtf 0001193125-23-137689.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 8, 2023	8-K	Report of unscheduled material events or corporate event	0001193125-23-137688.pdf 0001193125-23-137688.rtf 0001193125-23-137688.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 8, 2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-23-016258.pdf 0001628280-23-016258.rtf 0001628280-23-016258.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
April 28, 2023	8-K	Report of unscheduled material events or corporate event	0001193125-23-124259.pdf 0001193125-23-124259.rtf 0001193125-23-124259.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
April 28, 2023	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001193125-23-124284.pdf 0001193125-23-124284.rtf 0001193125-23-124284.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
April 28, 2023	ARS	An annual report to security holders	0001193125-23-125003.pdf 0001193125-23-125003.rtf View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax